Home » Topics » Regulatory

Regulatory
RSS

Metformin XT NDA accepted for filing by FDA

Feb. 24, 2003

Eligard 30 mg receives FDA approval

Feb. 20, 2003

Approvable letter issued for Zelapar

Feb. 20, 2003

Effexor XR approved for social anxiety disorder

Feb. 14, 2003

Bayer seeks expansion of aspirin labeling to include prevention of first heart attack

Feb. 14, 2003

AstraZeneca completes MRP in E.U. for Symbicort Turbuhaler in COPD

Feb. 12, 2003

FDA approves Zoloft for social anxiety disorder

Feb. 12, 2003

Fludara receives E.U. approval as first-line treatment for B-CLL

Feb. 11, 2003

Positive phase III results obtained for Metformin GR in type 2 diabetes

Feb. 5, 2003

First biologic therapy for psoriasis approved by FDA

Feb. 4, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 16, 2025.
Zusduri flurry ends; ‘set up’ at ODAC, Urogen prevails with FDA
BioWorld
During a conference call after the U.S. FDA approval of Zusduri (mitomycin), Urogen Pharma Ltd. CEO Liz Barrett offered candid observations about a...
23andme founder-led group outbids Regeneron for company
BioWorld
The 23andme Holding Co.’s saga came full circle with founder Anne Wojcicki regaining control of the bankrupt genetic testing company in a bidding battle against...
Elevidys’ second liver death hits Sarepta, sends DMD ripples
BioWorld
How the U.S. FDA might respond became a serious question for Wall Street as Sarepta Therapeutics Inc. made known a second death due to acute liver failure with...